These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 511213)
1. Radioassays of blood group M, N and T (Thomsen-Friedenreich) antigens. King MJ; Holburn AM Immunology; 1979 Sep; 38(1):129-36. PubMed ID: 511213 [TBL] [Abstract][Full Text] [Related]
2. Blood group N antigen precursor glycoproteins and N antigen precursor glycoproteins with Thomsen-Friedenreich (T) activity from human liver metastatic carcinomas. Otsuka K; Kudo T; Nakajima T; Ohkuma S Int J Biochem; 1991; 23(5-6):569-78. PubMed ID: 1648519 [TBL] [Abstract][Full Text] [Related]
3. Human urinary bladder carcinoma glycoconjugates expressing T-(Gal beta(1-3)GalNAc alpha 1-O-R) and T-like antigens: a comparative study using peanut agglutinin and poly- and monoclonal antibodies. Langkilde NC; Wolf H; Clausen H; Orntoft TF Cancer Res; 1992 Sep; 52(18):5030-6. PubMed ID: 1516058 [TBL] [Abstract][Full Text] [Related]
4. Specificity of reagents directed to the Thomsen-Friedenreich antigen and their capacity to bind to the surface of human carcinoma cell lines. Wolf MF; Koerner U; Schumacher K Cancer Res; 1986 Apr; 46(4 Pt 1):1779-82. PubMed ID: 2418954 [TBL] [Abstract][Full Text] [Related]
5. Lectins as markers for blood grouping. Khan F; Khan RH; Sherwani A; Mohmood S; Azfer MA Med Sci Monit; 2002 Dec; 8(12):RA293-300. PubMed ID: 12503049 [TBL] [Abstract][Full Text] [Related]
6. Relation of human blood-groups MN to cancer cell surface antigens and to receptors for oncogenic viruses. Springer GF; Desai PR Ann Clin Lab Sci; 1974; 4(4):294-8. PubMed ID: 4142544 [TBL] [Abstract][Full Text] [Related]
7. [Inhibitory activity of blood group antigens M and N in inhibition of virus hemagglutination reactions of influenza viruses]. Vojvodić S Med Pregl; 2000; 53(1-2):7-14. PubMed ID: 10953546 [TBL] [Abstract][Full Text] [Related]
8. Analysis of human tumor associated Thomsen-Friedenreich antigen. Samuel J; Noujaim AA; MacLean GD; Suresh MR; Longenecker BM Cancer Res; 1990 Aug; 50(15):4801-8. PubMed ID: 2196117 [TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of blood group N antigen precursor glycoproteins with Thomsen-Friedenreich (T) activity, N antigen precursor glycoproteins and T-active glycoproteins from cyst fluids of malignant ovarian clear cell carcinoma. Yanagi K; Ohyama K; Yamakawa T; Ohkuma S Int J Biochem; 1990; 22(9):1015-28. PubMed ID: 2282960 [TBL] [Abstract][Full Text] [Related]
10. Tumor-associated antigen defined by a monoclonal antibody against neuraminidase-treated human cancer cells. Ogasawara M; Takebe T; Ishii K Cancer Res; 1988 Jan; 48(2):412-7. PubMed ID: 3422053 [TBL] [Abstract][Full Text] [Related]
11. Use of a synthetic hapten in the demonstration of the Thomsen-Friedenreich (T) antigen on neuraminidase-treated human red blood cells and lymphocytes. Bray J; Lemieux RU; McPherson TA J Immunol; 1981 May; 126(5):1966-9. PubMed ID: 7217675 [TBL] [Abstract][Full Text] [Related]
12. Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin. Campbell BJ; Finnie IA; Hounsell EF; Rhodes JM J Clin Invest; 1995 Feb; 95(2):571-6. PubMed ID: 7860740 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the T antigen and T agglutinin in inbred rats. Noeman SA; Misra DN; Gill TJ Immunology; 1980 Feb; 39(2):219-29. PubMed ID: 6155326 [TBL] [Abstract][Full Text] [Related]
14. MNSs and Gerbich blood group systems. Moulds JJ; Dahr W Immunol Ser; 1989; 43():713-41. PubMed ID: 2490513 [TBL] [Abstract][Full Text] [Related]
15. Separation and biochemical characterization of blood group N antigen precursor glycoproteins with Thomsen-Friedenreich (T) activity, T-active glycoproteins and N antigen precursor glycoproteins from ascites of primary ovarian cancer patients. Hayashi S; Ohyama K; Yanagi K; Yamakawa T; Watanabe H; Hirakawa S; Ohkuma S Int J Biochem; 1990; 22(11):1315-24. PubMed ID: 2257955 [TBL] [Abstract][Full Text] [Related]
16. Products of digestion of tryptic M and N blood group glycopeptides with pronase. Waśniowska K; Lisowska E Arch Immunol Ther Exp (Warsz); 1981; 29(5):551-8. PubMed ID: 6181753 [TBL] [Abstract][Full Text] [Related]
17. Comparison of T-antigen expression in normal, premalignant, and malignant human colonic tissue using lectin and antibody immunohistochemistry. Yuan M; Itzkowitz SH; Boland CR; Kim YD; Tomita JT; Palekar A; Bennington JL; Trump BF; Kim YS Cancer Res; 1986 Sep; 46(9):4841-7. PubMed ID: 3731131 [TBL] [Abstract][Full Text] [Related]
18. Differential contributions of recognition factors of two plant lectins -Amaranthus caudatus lectin and Arachis hypogea agglutinin, reacting with Thomsen-Friedenreich disaccharide (Galbeta1-3GalNAcalpha1-Ser/Thr). Wu AM; Wu JH; Yang Z; Singh T; Goldstein IJ; Sharon N Biochimie; 2008; 90(11-12):1769-80. PubMed ID: 18809460 [TBL] [Abstract][Full Text] [Related]
19. Natural antibodies against the carcinoembryonic antigen (CEA) and a related antigen, NCA, in human sera. Frénoy N; Schauffler J; Cahour A; Burtin P Anticancer Res; 1987; 7(6):1229-33. PubMed ID: 3327450 [TBL] [Abstract][Full Text] [Related]
20. Extent of desialation of blood group MM, NN, and MN antigens required for reactivity with human anti-T antibody and Arachis hypogaea lectin. Springer GF; Desai PR J Biol Chem; 1982 Mar; 257(6):2744-6. PubMed ID: 7061447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]